Talis Treatment Information

ACTEMRA

Indication

Drug Summary

ACTEMRA® is indicated for the treatment of:

  • Moderate to severe Rheumatoid Arthritis

  • Giant Cell Arteritis

  • Polyarticular Juvenile Idiopathic Arthritis

  • Systemic Juvenile Idiopathic Arthritis

  • Cytokine Release Syndrome

ACTEMRA (tocilizumab) works by helping reduce the effects of a substance in the body that can cause inflammation. It can be administered by itself or with methotrexate and other non-biologic medications. It is commonly used to treat rheumatoid arthritis.

More Information

For more information, click here to visit the manufacturer's website: www.actemra.com/

 
 

ADUHELM

Indication

ADUHELM® is indicated for the treatment of:

  • Alzheimer's Disease

Drug Summary

ADUHELM (aducanumab-avwa) is an amyloid beta-directed antibody indicated for the treatment of Alzheimer’s disease. This indication is approved under accelerated approval based on reduction in amyloid beta plaques observed in patients treated with ADUHELM.

More Information

For more information, click here to visit the manufacturer's website:  www.aduhelm.com/

PHYSICIAN REFERRAL FORM

AVONEX

Indication

AVONEX® is indicated for the treatment of

  • Relapsing forms of multiple sclerosis (MS)

  • Clinically isolated syndrome

  • Relapsing-remitting disease

  • Active secondary progressive disease, in adults.

Drug Summary

Avonex is a brand of interferon beta-1a. Interferons are cytokines, which are proteins that cells use to communicate with each other to trigger the protective defenses of the immune system.

More Information

For more information, click here to visit the manufacturer's website:  www.avonex.com

 
 

AVSOLA

Indication

AVSOLA® is indicated for the treatment of

  • Adult & Pediatric Crohn's Disease

  • Adult & Pediatric ulcerative colitis

  • Rheumatoid Arthritis

  • Ankylosing Spondylitis

  • Psoriatic arthritis

  • Plaque psoriasis

Drug Summary

Avsola is proven biosimilar to Remicade and FDA approved for all Remicade indications. Avsola is indicated for reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy.

More Information

For more information, click here to visit the manufacturer's website:  www.avsola.com

 

BENLYSTA

Indication

BENLYSTA® is indicated for the treatment of:

  • Systemic Lupus Erythmatosus

Drug Summary

BENLYSTA (belimumab) is a biologic that reduces certain cells in your immune system, which aid in making lupus active. Adding it to other Lupus medications can maximize treatment outcomes.

More Information

For more information, click here to visit the manufacturer's website:  www.benlysta.com/

PHYSICIAN REFERRAL FORM

 

BIVIGAM

Indication

BIVIGAM® is indicated for the treatment of:

  • Primary Humoral Immunodeficiency

Drug Summary

BIVIGAM (Immune Globulin Intravenous (Human), 10% Liquid) is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. It is also used to increase the blood count (platelets) in persons with a certain blood disorder (idiopathic thrombocytopenia purpura-ITP).

More Information

 

CIMZIA

Indication

CIMZIA® is indicated for the treatment of:

  • Crohn's Disease

  • Rheumatoid Arthritis

  • Psoriatic Arthritis

  • Plaque Psoriasis

  • Ankylosing Spondylitis

  • Non-radiographic Axial Spondyloarthritis

  • Adult patients who have not tolerated other medications

Drug Summary

CIMZIA (certolizumab) is a biologic medication that reduces the effects of a substance in the body causing inflammation. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha.

More Information

For more information, click here to visit the manufacturer's website:  www.cimzia.com/

 

Indication

CINQAIR® is indicated for the treatment of:

  • Add-on maintenance treatment of patients with severe asthma aged 18 years and older, and with an eosinophilic phenotype.

Drug Summary

Cinqair (reslizumab) is a monoclonal antibody that affects the actions of the body's immune system. Reslizumab works by reducing levels of a certain type of white blood cell that may contribute to the symptoms of asthma.

More Information

For more information, click here to visit the manufacturer's website:  www.cinqair.com/

 

Indication

CINRYZE® is indicated for the treatment of:

  • Routine prophylaxis against angioedema attacks in adults, adolescents and pediatric patients (6 years of age and older) with Hereditary Angioedema (HAE)

Drug Summary

CINRYZE® (C1 esterase inhibitor [human]) increases plasma levels of C1-INH, thereby preventing the generation of excess bradykinin to reduce the risk of a swelling attack.

More Information

For more information, click here to visit the manufacturer's website:  www.cinryze.com/

 

Indication

ELAPRASE® is:

  •  Hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme

Drug Summary

The active substance in Elaprase, idursulfase, is a copy of the human enzyme iduronate-2-sulfatase. It replaces the enzyme that is missing or defective in patients with Hunter syndrome. Supplying the enzyme will help to break down GAGs and stop them building up in body tissue, thereby helping to improve the symptoms of the disease.

 

More Information

For more information, click here to visit the manufacturer's website:  www.elaprase.com/

 

Indication

ENTIVIO® is indicated for the treatment of:

  • Ulcerative Colitis

  • Crohn's Disease

Drug Summary

ENTIVIO (vedolizumab) focuses on the GI tract, blocking the movement of white cells located in the gut, which helps control inflammation. It may reduce symptoms, induce and maintain remission, heal the intestinal lining or allow patients to reduce or stop the use of corticosteroids.

More Information

For more information, click here to visit the manufacturer's website:  www.entivio.com/

Indication

FASENRA® is indicated for the treatment of:

  • Severe eosinophilic asthma

Drug Summary

Fasenra, benralizumab, is designed to target and remove eosinophils from the blood. Fasenra is an add-on maintenance treatment for patients aged 12 and older.

More Information

For more information, click here to visit the manufacturer's website:  www.fasenra.com/

PHYSICIAN REFERRAL FORM

 

Indication

FERAHEME® is for the treatment of:

  •  Iron Deficiency Anemia in Adults

Drug Summary

Feraheme is in a class of medicines called iron replacement products. It works by replenishing iron so that the body can make more red blood cells that carry oxygen throughout the body.

More Information

 

Indication

FERRLECIT® is for the treatment of:

  •  Iron Deficiency Anemia in Adults

Drug Summary

Hemoglobin carries oxygen through your blood to tissues and organs. Myoglobin helps your muscle cells store oxygen. Ferriecit is used to treat iron deficiency anemia (a lack of red blood cells caused by having too little iron in the body) in adults and children at least 6 years old.

More Information

For more information, click here to visit the manufacturer's website:  Sanofi-Ferrlecit

 

FLEBOGAMMA

Indication

Flebogamma 10% DIF is an immune globulin intravenous (human), indicated for
treatment of:

  • Primary (inherited) Immunodeficiency (PI)

  • Chronic Primary Immune Thrombocytopenia (ITP) in patients 2 years of
    age and older

Drug Summary

Flebogamma DIF works by restoring abnormally low IgG levels to their normal range in the blood. At higher doses, it can help to adjust an abnormal immune system and modulate the immune response.

Flebogamma DIF is made like Flebogamma, another medicine containing human normal immunoglobulin, with some additional steps in the purification of the product from human plasma.

More Information

For more information, click here to visit the manufacturer's website:  Grifols-Flebogamma

 
 

GAMMAGARD

Indication

GAMMAGARD is a treatment:

  • Primary humoral
    immunodeficiency (PI) in adult and pediatric patients two years of
    age or older

  • Multifocal Motor Neuropathy

Drug Summary

GAMMAGARD LIQUID is a ready-to-use liquid medicine that contains immunoglobulin G, or IgG, antibodies, which protect the body against infection. These antibodies, collected from the plasma of healthy people, replace the missing antibodies in primary immunodeficiency (PI) patients.

More Information

For more information, click here to visit the manufacturer's website: www.gammagard.com

 

GAMMAPLEX

Indication

GAMMAGARD is a treatment:

  • Primary humoral immunodeficiency (PI) in adults and pediatric patients two
    years of age and older

  • Chronic immune thrombocytopenic purpura (ITP)

Drug Summary

GAMMPLEX is used to strengthen the body's natural defense system (immune system) to lower the risk of infection in persons with a weakened immune system. This medication is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. It is also used to increase the blood count (platelets) in persons with a certain blood disorder (idiopathic thrombocytopenia purpura-ITP). 

More Information

For more information, click here to visit the manufacturer's website: www.gammaplex.com

 

GAMMUNEX-C

Indication

GAMMUNEX-C is a treatment:

  • Primary Humoral Immunodeficiency (PI) in patients 2 years of age and older

  • Idiopathic Thrombocytopenic Purpura (ITP)

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Drug Summary

Treatment with GAMUNEX-C provides healthy antibodies to block the immune and inflammatory processes that attack and destroy myelin.

More Information

For more information, click here to visit the manufacturer's website: www.gamunex-c.com

 

GLASSIA

Indication

GLASSIA is a treatment:

  • Emphysema due to congenital deficiency of alpha-1-proteinase inhibitor (Alpha1-PI), also known as alpha1-antitrypsin

Drug Summary

GLASSIA increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels of Alpha1 -PI.

More Information

For more information, click here to visit the manufacturer's website: Glassia

 

INFED

Indication

INFED is a treatment for:

  • Documented iron deficiency

Drug Summary

INFeD (iron dextran injection USP) is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use.

More Information

For more information, click here to visit the manufacturer's website: Infed

PHYSICIAN REFERRAL FORM

INFLECTRA

Indication

INFLECTRA is a treatment for:

  • Rheumatoid arthritis

  • Adult ulcerative colitis

  • Plaque psoriasis

  • Psoriatic arthritis 

  • Ankylosing spondylitis

  • Adult and pediatric Crohn’s disease.

Drug Summary

INFLECTRA is indicated for reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy.

More Information

For more information, click here to visit the manufacturer's website: Inflectra

 
 

INJECTAFER

Indication

INJECTAFER is a treatment for:

  • Iron Deficiency Anemia

Drug Summary

Injectafer is indicated for the treatment of iron deficiency anemia in adult patients: who have intolerance to oral iron or have had unsatisfactory response to oral iron;

• who have non-dialysis dependent chronic kidney disease.

More Information

For more information, click here to visit the manufacturer's website: Injectafer

PHYSICIAN REFERRAL FORM

IVIG

Indication

IVIg is indicated for the treatment of:

  • Autoimmune Disorders

    • Lupus​

    • Myositis

    • Guillain-Barre Syndrome

  • Immunodeficiencies

  • Idiopathic Diseases

    • Kawasaki Disease​

  • Neurological Diseases

    • Myasthenia Gravis​

    • Multiple Sclerosis

    • Chronic Inflammatory Demyelinating polyneuropathy

  • Infections

  • Complications of organ transplants

Drug Summary

IVIg or Intravenous Immunoglobulin is sometimes administered instead of other medications, such as immunosuppressants, corticosteroids or biologic drugs to help treat immune system disorders. They are extracted from the plasma of healthy blood donors.

More Information

For more information, click here to visit website: https://www.webmd.com/a-to-z-guides/immunoglobulin-therapy

PHYSICIAN REFERRAL FORM

 

KRYSTEXXA

Indication

KRYSTEXXA (pegloticase) is a treatment for:

  • Chronic Gout

Drug Summary

KRYSTEXXA (pegloticase) is a prescription medicine used in adults to help reduce the signs and symptoms of gout that are not controlled by other treatments.

More Information

For more information, click here to visit the manufacturer's website: www.krystexxa.com

PHYSICIAN REFERRAL FORM

 
 

LEQVIO

Indication

LEQVIO® (inclisiran)is a treatment for:

  • Familial Hypercholesterolemia

  • Family History of Familial Hypercholesterolemia

  • Lowering bad cholesterol (LDL-C) in people with heart disease on a statin

Drug Summary

LEQVIO® (inclisiran) is an injectable prescription medicine used along with diet and other lipid-lowering medicines in adults who need additional lowering of "bad" cholesterol

(LDL-C) and have known cardiovascular disease and/or heterozygous familial hypercholesterolemia (HeFH), an inherited condition that causes high levels of LDL-C. It is not known if LEQVIO can decrease problems related to high cholesterol, such as heart attacks or stroke.

More Information

For more information, click here to visit the manufacturer's website: www.leqvio.com

PHYSICIAN REFERRAL FORM

 

PHYSICIAN REFERRAL FORM

NUCALA

Indication

NUCALA is a treatment for:

  • Severe asthma aged 6 years and older, and with an eosinophilic phenotype

  • Adult patients with eosinophilic granulomatosis with polyangiitis (EGPA)

  • Hypereosinophilic syndrome (HES) for ≥6 months without an identifiable non-hematologic secondary cause

Drug Summary

Nucala works to reduce the number of eosinophils in your body. These are a type of white blood cell that’s involved in causing inflammation (swelling).

More Information

For more information, click here to visit the manufacturer's website: www.nucala.com

 

NULOJIX

Indication

NULOJIX is a treatment for:

  • Prophylaxis of organ rejection in adult patients receiving a kidney transplant. 

Drug Summary

The active substance in Nulojix, belatacept, is an immunosuppressant medicine. It suppresses the
activity of ‘T cells’, immune system cells that can become involved in organ rejection.
T cells must be ‘activated’ before they work. This happens when certain molecules attach to receptors
on the surface of the T cells. Belatacept has been designed to attach to two of these molecules called
CD80 and CD86. This stops them activating the T cells, helping to prevent organ rejection.

More Information

For more information, click here to visit the manufacturer's website: www.nulojix.bmscustomerconnect.com/

 

PHYSICIAN REFERRAL FORM

OCREVUS

Indication

OCREVUS® is indicated for the treatment of:

  • Multiple Sclerosis

Drug Summary

OCREVUS (ocrelizumab) is an immunosuppressive drug used in the treatment of Relapsing and Primary Multiple Sclerosis.

More Information

For more information, click here to visit the manufacturer's website:  www.ocrevus.com/

OCTAGAM

Indication

OCTAGAM® is indicated for the treatment of:

  • Idiopathic thrombocytopenic purpura (ITP)

  • Primary Humoral Immunodeficiency

Drug Summary

OCTAGAM [Immune Globulin Intravenous (Human)], is used to strengthen the body's natural immune system to lower the risk of infection in persons with weakened immune systems.

More Information

For more information, click here to visit the manufacturer's website:  www.octagamus.com/

 
 

ORENCIA

Indication

ORENCIA® is indicated for the treatment of:

  • Adult Rheumatoid Arthritis​

  • Polyarticular Juvenile Idiopathic Arthritis (pJIA)

  • Adult Psoriatic Arthritis (PsA)​

Drug Summary

ORENCIA (abatacept) prevents your body's immune system from attacking healthy tissue. It can aid patients who are not achieving relief through their current RA regimens. It is not used as a cure for any autoimmune disorder and will only treat the symptoms of the condition.

More Information

For more information, click here to visit the manufacturer's website:  www.orencia.com/

 

PRIVIGEN

Indication

PRIVIGEN® is indicated for the treatment of:

  • Primary humoral immunodeficiency (PI)

Drug Summary

Privigen helps protect the health of people with PI by supplying their immune systems with antibodies to help prevent infections. Privigen can also help improve motor function in adults with CIDP. For people 15 years and older with chronic ITP, Privigen can raise platelet counts to help prevent bleeding.

More Information

For more information, click here to visit the manufacturer's website:  https://www.privigen.com/

 

PHYSICIAN REFERRAL FORM

PROLIA

Indication

PROLIA® is indicated for the treatment of:

  • Osteoporosis

Drug Summary

PROLIA (denosumab) is a human-derived antibody that inactivates the body's bone-breakdown mechanism. It is typically administered twice a year to post-menopausal women with osteoporosis and high-risk fracture, patients with osteoporosis that other treatments have failed and patients who cannot tolerate other osteoporosis treatments.

More Information

For more information, click here to visit the manufacturer's website:  www.prolia.com/

PROLASTIN-C

Indication

PROLASTIN-C is a treatment for:

  • Emphysema due to severe hereditary deficiency of Alpha1-PI (alpha1-
    antitrypsin deficiency).

Drug Summary

Prolastin-C is a concentrated form of AAT that is made from blood plasma. Prolastin-C can be effective at raising the levels of AAT protein in the bloodstream of a person with AAT deficiency.1,2

More Information

For more information, click here to visit the manufacturer's website: www.prolastin.com

 
 

REMICADE

Indication

REMICADE® is indicated for the treatment of:

  • Rheumatoid arthritis

  • Crohn's Disease

  • Ulcerative Colitis

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Plaque Psoriasis

Drug Summary

REMICADE (infliximab) is a monoclonal antibody that works to enhance and improve the immune system. 

More Information

For more information, click here to visit the manufacturer's website:  www.remicade.com/

 

RENFLEXIS

Indication

RENFLEXIS® is indicated for the treatment of:

  • Rheumatoid arthritis in combination with methotrexate

  • Adult & Pediatric Crohn's Disease

  • Adult & Pediatric Ulcerative Colitis

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Plaque Psoriasis

Drug Summary

RENFLEXIS (infliximab-abda) is a biosimilar to Remicade that can reduce the underlying cause of the inflammation that can lead to symptoms.

 

For patients with Chrohn's Disease, Pediatric Crohn's Disease and Pediatric Ulcerative Colitis, Renflexis may also induce and maintain remission.

For adult patients with Ulcerative Colitis, Renflexis may also induce and maintain remission, promote intestinal healing and reduce or stop the need for steroid therapy.

For patients with Rheumatoid Arthritis and Psoriatic Arthritis, Renflexis may also stop further joint damage and improve physical function.

More Information

For more information, click here to visit the manufacturer's website:  www.renflexis.com/

 

RITUXAN

Indication

RITUXAN® is indicated for the treatment of:

  • Rheumatoid Arthritis​

  • Pemphigus Vulgaris

  • GPA/MPA Vasculitis

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Plaque Psoriasis

Drug Summary

RITUXAN (rituximab) is a genetically engineered chimeric/human monoclonal antibody. It is used in combination with other cancer medications to treat Non-Hodgkins Lymphoma by slowing and stopping cell growth. It can also be used to treat rheumatoid arthritis by decreasing joint pain and swelling.

More Information

For more information, click here to visit the manufacturer's website:  www.rituxan.com/

SAPHNELO

Indication

SAPHNELO® is indicated for the treatment of:

  • Moderate to severe systemic lupus erythmatosus (SLE), who are receiving standard treatment

Drug Summary

SAPHNELO (anifrolumab-fnia) is a monoclonal antibody infusion therapy that works by targeting type I IFN receptors

More Information

For more information, click here to visit the manufacturer's website:  www.saphnelo.com/

 

SD GAMMAKED

Indication

SD GAMMAKED® is indicated for the treatment of:

  • Primary Humoral Immunode ciency (PI) in patients 2 years of age and older

  • Idiopathic Thrombocytopenic Purpura

    Chronic In ammatory Demyelinating Polyneuropathy (CIDP) 

Drug Summary

SD GAMMAKED raises platelet counts and prevents bleeding in patients with ITP who are scheduled to undergo surgery. It is also designed to improve neuromuscular disability, as well as to prevent relapse of primary humoral immunodeficiency (PI) in patients who are two years of age or older.

More Information

For more information, click here to visit the manufacturer's website:  www.gammaked.com/

 

SIMPONI ARIA

Indication

SIMPONI ARIA® is indicated for the treatment of:

  • Rheumatoid Arthritis​

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Polyarticular Juvenile Idiopathic arthritis

Drug Summary

SIMPONI ARIA (golimumab) is an immunosuppresive drug used to treat autoimmune diseases by reducing inflammation.

More Information

For more information, click here to visit the manufacturer's website:  www.simponiaria.com/

PHYSICIAN REFERRAL FORM

 
 

SOLIRIS

Indication

SOLIRIS® is indicated for the treatment of:

  • Paroxysmal Nocturnal Hemoglobinuria

  • Atypical Hemolytic Uremic Syndrome

  • Generalized Myasthenia Gravis

  • Neuromyelitis Optica Spectrum Disorder

Drug Summary

SOLIRIS (eculizumab) is a monoclonal antibody in the immunosuppressive drug category used for the treatment of hemolytic blood disorders. It works by selectively slowing down the complement cascade in the human body

More Information

For more information, click here to visit the manufacturer's website:  www.soliris.com/

SOLU-MEDROL

Indication

SOLU-MEDROL® is indicated for the treatment of:

  • Rheumatoid Arthritis​

  • Pemphigus Vulgaris

  • GPA/MPA Vasculitis

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Plaque Psoriasis

Drug Summary

SOLU-MEDROL (methylprednisolone sodium succinate for injection) is part of a potent class of anti-inflammatory agents known as corticosteroids. It is used for the treatment of inflammation, severe allergies and flares of chronic illnesses.

More Information

For more information, click here to visit the manufacturer's website:  Pfizer

 
 

STELARA IV

Indication

STELARA® is indicated for the treatment of:

  • Crohn's Disease

  • Psoriatic Arthritis

  • Plaque Psoriasis

Drug Summary

STELARA (ustekinubab) is an immunosuppressive drug that reduces inflammation due to various autoimmune diseases.

More Information

For more information, click here to visit the manufacturer's website:  www.stelarainfo.com/

 

TEPEZZA

Indication

TEPEZZA® is indicated for the treatment of:

  • Thyroid Eye Disease

Drug Summary

TEPEZZA (teprotumumab-trbw) is an infusion therapy used to treat the cause of Thyroid Eye Disease and improve symptoms including eye pain, redness and swelling. Patients may experience improved visual ability, physical appearance and double-vision.

More Information

For more information, click here to visit the manufacturer's website:  www.tepezza.com/

PHYSICIAN REFERRAL FORM

 

TYSABRI

Indication

TYSABRI® is indicated for the treatment of:

  • Multiple Sclerosis

  • Crohn's Disease

Drug Summary

TYSABRI (natalizumab) works by impairing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and brain/spinal cord. It is a laboratory-produced antibody and has been proven effective in treating MS symptoms while preventing relapse, vision loss and cognitive decline. It is also used to treat Crohn's Disease.

More Information

For more information, click here to visit the manufacturer's website:  www.tysabri.com

UPLIZNA

Indication

UPLIZNA® is indicated for the treatment of:

  • Neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive

Drug Summary

UPLIZNA (inebilizumab-cdon) is an antibody therapy used to reduce relapses that may lead to permanent disability.

More Information

For more information, click here to visit the manufacturer's website:  www.uplizna.com/

 

VENOFER

Indication

VENOFER® is indicated for the treatment of:

  • Gastrointestinal Conditions

  • Chronic Kidney Disease

  • Women's Health Conditions

  • Heart Failure

  • Cancer

Drug Summary

VENOFER® (iron sucrose) injection is indicated for the treatment of iron deficiency anemia in adult and pediatric (2 years and older) with chronic kidney disea

More Information

For more information, click here to visit the manufacturer's website:  www.venofer.com/

PHYSICIAN REFERRAL FORM

 
 

VYEPTI

Indication

VYEPTI® is indicated for the treatment of:

  • Migraine in adults

Drug Summary

VYEPTI (eptinezumab-jjmr) is a calcitonin gene-related peptide antagonist indicated for the preventive treatment of migraine in adults.

More Information

For more information, click here to visit the manufacturer's website:  www.vyepti.com/

PHYSICIAN REFERRAL FORM

VYVGART

Indication

VYVGART® is indicated for the treatment of:

  • Generalized Myasthenia Gravis in adult patients who are anti-acetylcholine receptor antibody (AChR) positive

Drug Summary

VYVGART (efgartigimod alfa-fcab) is an infusion therapy that reduces the level of harmful AChR antibodies that cause the symptoms of generalized myasthenia gravis.

More Information

For more information, click here to visit the manufacturer's website:  www.vygart.com/

 
 

XOLAIR

Indication

XOLAIR® is indicated for the treatment of:

  • Allergic Asthma

  • Chronic Idiopathic Urticaria (UCI)

  • Nasal Polyps

Drug Summary

XOLAIR (omalizumab) is an antibody that helps decrease asthma responses in adults and children who are at least 12 years old. It is prescribed for patients not finding relief from an inhaler or corticosteroids. It is also used for conditions causing chronic hives.

More Information

For more information, click here to visit the manufacturer's website:  www.xolair.com/

PHYSICIAN REFERRAL FORM